← Back
Data updated: Mar 10, 2026
TIANJIN KINGYORK
Pharmaceuticals
TIANJIN KINGYORK is a generic drug manufacturer with 1 FDA-approved products.
2021
Since
1
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-02-19
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-12-19
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-11-13
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-11-13
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-11-06
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-05-07
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2021-04-20
- Latest
- 2023-09-18
- Applications
- 1